GS-TCGA: Gene Set-Based Analysis of The Cancer Genome Atlas
- PMID: 38436570
- DOI: 10.1089/cmb.2023.0278
GS-TCGA: Gene Set-Based Analysis of The Cancer Genome Atlas
Abstract
Most tools for analyzing large gene expression datasets, including The Cancer Genome Atlas (TCGA), have focused on analyzing the expression of individual genes or inference of the abundance of specific cell types from whole transcriptome information. While these methods provide useful insights, they can overlook crucial process-based information that may enhance our understanding of cancer biology. In this study, we describe three novel tools incorporated into an online resource; gene set-based analysis of The Cancer Genome Atlas (GS-TCGA). GS-TCGA is designed to enable user-friendly exploration of TCGA data using gene set-based analysis, leveraging gene sets from the Molecular Signatures Database. GS-TCGA includes three unique tools: GS-Surv determines the association between the expression of gene sets and survival in human cancers. Co-correlative gene set enrichment analysis (CC-GSEA) utilizes interpatient heterogeneity in cancer gene expression to infer functions of specific genes based on GSEA of coregulated genes in TCGA. GS-Corr utilizes interpatient heterogeneity in cancer gene expression profiles to identify genes coregulated with the expression of specific gene sets in TCGA. Users are also able to upload custom gene sets for analysis with each tool. These tools empower researchers to perform survival analysis linked to gene set expression, explore the functional implications of gene coexpression, and identify potential gene regulatory mechanisms.
Keywords: GSEA; TCGA; cancer; survival analysis.
Similar articles
-
Assessment of Gene Set Enrichment Analysis using curated RNA-seq-based benchmarks.PLoS One. 2024 May 16;19(5):e0302696. doi: 10.1371/journal.pone.0302696. eCollection 2024. PLoS One. 2024. PMID: 38753612 Free PMC article.
-
Web-TCGA: an online platform for integrated analysis of molecular cancer data sets.BMC Bioinformatics. 2016 Feb 6;17:72. doi: 10.1186/s12859-016-0917-9. BMC Bioinformatics. 2016. PMID: 26852330 Free PMC article.
-
The Cancer Omics Atlas: an integrative resource for cancer omics annotations.BMC Med Genomics. 2018 Aug 8;11(1):63. doi: 10.1186/s12920-018-0381-7. BMC Med Genomics. 2018. PMID: 30089500 Free PMC article.
-
A survey and evaluation of Web-based tools/databases for variant analysis of TCGA data.Brief Bioinform. 2019 Jul 19;20(4):1524-1541. doi: 10.1093/bib/bby023. Brief Bioinform. 2019. PMID: 29617727 Free PMC article. Review.
-
The RNA world: from experimental laboratory to "in silico" approach. Part 1: User friendly RNA expression databases portals.Rep Pract Oncol Radiother. 2024 Jun 6;29(2):245-257. doi: 10.5603/rpor.99675. eCollection 2024. Rep Pract Oncol Radiother. 2024. PMID: 39143966 Free PMC article. Review.
Cited by
-
Small nucleolar RNAs: the hidden precursors of cancer ribosomes.Philos Trans R Soc Lond B Biol Sci. 2025 Mar 6;380(1921):20230376. doi: 10.1098/rstb.2023.0376. Epub 2025 Mar 6. Philos Trans R Soc Lond B Biol Sci. 2025. PMID: 40045787 Review.
-
Weight Loss Reverses the Effects of Aging and Obesity on Mammary Tumor Immunosuppression and Progression.Cancer Prev Res (Phila). 2025 Aug 1;18(8):453-463. doi: 10.1158/1940-6207.CAPR-24-0514. Cancer Prev Res (Phila). 2025. PMID: 40231562
-
Exploration of SUSD3 in pan-cancer: studying its role, predictive analysis, and biological significance in various malignant tumors in humans.Front Immunol. 2025 Mar 21;16:1521965. doi: 10.3389/fimmu.2025.1521965. eCollection 2025. Front Immunol. 2025. PMID: 40191190 Free PMC article.
-
Myeloid Zinc Finger 1: insights into its oncogenic potential, prognostic value, and impact on immune microenvironment across cancers.Front Immunol. 2025 Jun 27;16:1591912. doi: 10.3389/fimmu.2025.1591912. eCollection 2025. Front Immunol. 2025. PMID: 40655141 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical